Events

Videos

Podcasts

Articles

Clinical

® Clinical Focus page includes a listing of all specialities covered across  OncLive.com, including breast cancer, lung cancer, gastrointestinal cancers, genitourinary cancers, hematologic malignancies, and gynecologic cancers. Each individual specialty page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances in both the localized and metastatic settings, and ongoing research.


Emerging Therapies for Extensive Stage SCLC and CASPIAN Trial

Frontline and R/R Therapy and PD-L1 Targeted Therapy for SCLC

The ADRIATIC Trial in Limited-Stage SCLC

The CASPIAN Trial in Extensive-Stage SCLC

Immunotherapy in Relapsed-Refractory SCLC

Frontline Therapy Approaches for Small Cell Lung Cancer

First-line Immunotherapy: IMPower133 Regimen

Immunotherapy Toxicity Profile

Negative I/O Trials: CheckMate331 and CheckMate 451

Checkpoint Inhibitors in Second and Third-line

SCLC Therapy: First-line Options Prior to Immunotherapy

The Initial Approach to SCLC Treatment

Small Cell Lung Cancer: Future Directions in Care

I-O Strategies in Relapsed/Refractory SCLC

Frontline I-O Strategies in SCLC: Practical Implications

Results From the CASPIAN Trial in SCLC

Small Cell Lung Cancer: Interpreting Data From IMpower133

Current Frontline Management of Small Cell Lung Cancer

Treatment with entrectinib led to an overall response rate of 77% and a median duration of response of 24.6 months in patients with ROS1 fusion–positive non–small cell lung cancer, according to updated findings of a pooled analysis published in Lancet Oncology.

Published Entrectinib Data Demonstrate Encouraging Responses in ROS1+ NSCLC

Mary J. Fidler, MD, discusses the utility of dacomitinib (Vizimpro) in patients with EGFR-mutant non–small cell lung cancer.

Dr. Fidler on the Utility of Dacomitinib in EGFR-Mutant NSCLC

The OncLive Lung Cancer condition center page is a comprehensive resource for clinical news and expert insights on non–small cell lung cancer, small cell lung cancer, mesothelioma, and more. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in lung cancer.

Lung Cancer

JAN-22-OSD1275 - /clinical/lung-cancer

Lung Cancer | Specialty